Novo CEO pressed by Senate to chop prices of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen informed lawmakers the organization would take into consideration new talks with insurers about the record selling prices of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://labelthefigurewiththeitem18406.blue-blogs.com/37473057/5-easy-facts-about-healthcare-news-described